Role of cannabinoid receptors in alcoholic hepatic injury: Steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts

Liver International

Volumn 31, Issue 6, 2011, Pages 860-870

  Trebicka, Jonel ^a   Racz, Ildiko ^a   Siegmund, Sören V ^a   Cara, Erlind ^a   Granzow, Michaela ^a   Schierwagen, Robert ^a   Klein, Sabine ^a   Wojtalla, Alexandra ^a   Hennenberg, Martin ^a   Huss, Sebastian ^a   Fischer, Hans Peter ^a   Heller, Jörg ^a   Zimmer, Andreas ^a   Sauerbruch, Tilman ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Alcohol; Cannabinoid receptors; Fibrogenesis; Inflammation; Steatosis

Indexed keywords

ALCOHOL; ALPHA SMOOTH MUSCLE ACTIN; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CATHEPSIN D; CD3 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; COLLAGEN; CYCLINE; CYTOKINE; EOSIN; FATTY ACID SYNTHASE; FLUORESCENT DYE; HEMALAUN; HYDROXYPROLINE; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OIL RED O; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROCOLLAGEN; PROCOLLAGEN 1A; SIRIUS RED; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FATTY LIVER; FEMALE; FIBROGENESIS; HEPATITIS; HISTOPATHOLOGY; INFLAMMATION; LIPOGENESIS; LIVER; LIVER FIBROSIS; LIVER HOMOGENATE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STELLATE CELL; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; WILD TYPE;

EID: 79955635993     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02496.x     Document Type: Article

References (36)

1. Pinzani M. PDGF and signal transduction in hepatic stellate cells. Front Biosci 2002; 7: d1720-6.
2. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-18.
3. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006; 10: 76-99.
4. Parola M, Marra F, Pinzani M. Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Asp Med 2008; 29: 58-66.
5. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-69.
6. Friedman S. The hepatic stellate cell. Semin Liver Dis 2001; 1: 307-452.
7. Julien B, Grenard P, Teixeira-Clerc F, et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 2005; 128: 742-55.
8. Siegmund SV, Qian T, De Minicis S, et al. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J 2007; 21: 2798-806.
9. Siegmund SV, Seki E, Osawa Y, et al. Fatty acid amide hydrolase determines anandamide-induced cell death in the liver. J Biol Chem 2006; 281: 10431-8.
10. Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 2005; 41: 1085-95.
11. Jeong WI, Osei-Hyiaman D, Park O, et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 2008; 7: 227-35.
12. Osei-Hyiaman D, Depetrillo M, Pacher P, et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005; 115: 1298-305.
13. Teixeira-Clerc F, Julien B, Grenard P, et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 2006; 12: 671-6.
14. Van de poorten D, shahidi M, Tay E, et al. Hepatitis C virus induces the cannabinoid receptor 1. PLoS One 2010; 5: e12841.
15. Munoz-Luque J, Ros J, Fernandez-Varo G, et al. Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J Pharmacol Exp Ther 2008; 324: 475-83.
16. De Gottardi A, Spahr L, Ravier-Dall'a F, Hadengue A. Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes. Liver Int 30: 1482-9.
17. Deveaux V, Cadoudal T, Ichigotani Y, et al. Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One 2009; 4: e5844.
18. Hezode C, Zafrani ES, Roudot-Thoraval F, et al. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology 2008; 134: 432-9.
19. Mallat A, Hezode C, Lotersztajn S. Environmental factors as disease accelerators during chronic hepatitis C. J Hepatol 2008; 48: 657-65.
20. Racz I, Schurmann B, Karpushova A, et al. The opioid peptides enkephalin and beta-endorphin in alcohol dependence. Biol Psychiatry 2008; 64: 989-97.
21. Racz I, Bilkei-Gorzo A, Toth ZE, et al. A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 2003; 23: 2453-8.
22. Trebicka J, Hennenberg M, Laleman W, et al. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology 2007; 46: 242-53.
23. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
24. Trebicka J, Hennenberg M, Odenthal M, et al. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J Hepatol 2010; 53: 702-12.
25. Huss S, Schmitz J, Goltz D, et al. Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis. Fibrogenesis Tissue Repair 2010; 3: 10.
26. Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 1981; 112: 70-5.
27. Moles A, Tarrats N, Fernandez-Checa JC, Mari M. Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential. Hepatology 2009; 49: 1297-307.
28. Mendez-Sanchez N, Zamora-Valdes D, Pichardo-Bahena R, et al. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease. Liver Int 2007; 27: 215-9.
29. Osei-Hyiaman D, Liu J, Zhou L, et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 2008; 118: 3160-9.
30. Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009; 33: 191-205.
31. Gordon S. Macrophage-restricted molecules: role in differentiation and activation. Immunol Lett 1999; 65: 5-8.
32. Valles SL, Blanco AM, Azorin I, et al. Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes. Alcohol Clin Exp Res 2003; 27: 1979-86.
33. Sherwood TA, Nong L, Agudelo M, et al. Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes. J Neuroimmune Pharmacol 2009; 4: 476-88.
34. Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P. Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology 2010; 215: 598-605.
35. Cencioni MT, Chiurchiu V, Catanzaro G, et al. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One 5: e8688.
36. Avraham Y, Zolotarev O, Grigoriadis NC, et al. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am J Gastroenterol 2008; 103: 3047-56.